✦ LIBER ✦

Intraperitoneal hyperthermic chemotherapy in ovarian cancer

✍ Scribed by J. Gori; R. CastañO; M. Toziano; D. Häbich; J. Staringer; D.G.B. De Quirós; N. Felci

Book ID: 109085426
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 125 KB
Volume: 15
Category: Article
ISSN: 1048-891X
DOI: 10.1111/j.1525-1438.2005.15209.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Consolidation hyperthermic intraperitone

Consolidation hyperthermic intraperitoneal chemotherapy using paclitaxel in patients with epithelial ovarian cancer

✍ Jin Hwi Kim; Joon Mo Lee; Ki Sung Ryu; Yong Seok Lee; Yong Gyu Park; Soo Young H 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

## Abstract ## Background We evaluated the efficacy and feasibility of hyperthermic intraperitoneal chemotherapy (HIPEC) using paclitaxel as consolidation therapy in patients with epithelial ovarian cancer. ## Methods Between November 1999 and January 2004, 18 patients with a negative second‐loo

Intraoperative hyperthermic intraperiton

Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results

✍ Terence C. Chua; Greg Robertson; Winston Liauw; Rhonda Farrell; Tristan D. Yan; 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 389 KB

The role of hyperthermic intraoperative

The role of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal carcinomatosis in recurrent ovarian cancer

✍ Francisco C. Muñoz-Casares; Sebastián Rufián; María J. Rubio; Carlos J. Díaz; Ra 📂 Article 📅 2009 🏛 Springer Milan 🌐 Spanish ⚖ 410 KB

Safety and potential benefit of hyperthe

Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer

✍ Franco Roviello; Enrico Pinto; Giovanni Corso; Corrado Pedrazzani; Stefano Carus 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 1 views

## Abstract ## Objectives To analyze the outcomes of cytoreductive surgery and HIPEC in patients with peritoneal carcinomatosis from ovarian cancer. ## Methods Fifty‐three patients with peritoneal carcinomatosis from primary (45 cases) and recurrent (8 cases) ovarian cancer were previously treat

Oxaliplatin-based hyperthermic intraperi

Oxaliplatin-based hyperthermic intraperitoneal chemotherapy in primary or recurrent epithelial ovarian cancer: A pilot study of 31 patients

✍ Jean-Sebastien Frenel; Christophe Leux; Luc Pouplin; Gwenael Ferron; Dominique B 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 1 views

Cytoreductive surgery (peritonectomy pro

Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer

✍ Angelo Di Giorgio; Enzo Naticchioni; Daniele Biacchi; Simone Sibio; Fabio Accarp 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 1 views

## Abstract ## BACKGROUND. Because of scarce data from larger series and nonhomogeneous selection criteria, further information is needed on peritonectomy with hyperthermic intraperitoneal chemotherapy (HIPEC) in managing patients with ovarian peritoneal carcinomatosis. ## METHODS. In an open, p